C. Griffith

发表

Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists.

M. Dowsett, S. Ebbs, J. Salter, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

K. Wood, C. Griffith, D. Hemming, 1998 .

HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer

M. Dowsett, M. Cheang, D. Rea, 2022, EBioMedicine.

Proliferation and Apoptosis as Markers of Benefit in Neoadjuvant Endocrine Therapy of Breast Cancer

M. Dowsett, S. Ebbs, J. Salter, 2006, Clinical Cancer Research.

Human spleen cells mediating natural killing: Altered natural cytotoxicity of spleen effector cells from patients with carcinoma

C. Hawrylowicz, C. Griffith, Selman A. Ali, 2004, Journal of Cancer Research and Clinical Oncology.

False-negative results of Haemoccult test in colorectal cancer

J. Saunders, C. Griffith, 1981, British medical journal.

False-negative results of Hemoccult test in colorectal cancer.

J. Saunders, C. Griffith, D. Turner, 1981, British medical journal.

p53 protein expression in ductal carcinoma in situ (DCIS) of the breast

R. Perry, P. Rajan, C. Griffith, 1997, Breast Cancer Research and Treatment.

Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival.

M. Dowsett, S. Ebbs, J. Salter, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Granulomatous mastitis can mimic breast cancer on clinical, radiological or cytological examination: a cautionary tale.

R. Heer, C. Griffith, J. Shrimankar, 2003, Breast.

Gynaecomastia, neurofibromatosis and breast cancer.

F. Douglas, Colin H. Wilson, C. Griffith, 2004, Breast.

Should breast biopsy cavities be drained?

W. Angerson, L. Mclean, C. Griffith, 1994, Annals of the Royal College of Surgeons of England.

United Kingdom National Health Service, Cancer Services Collaborative "Improvement Partnership", Redesign of Cancer Services: A National Approach.

C. Griffith, J. Turner, 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Size does matter: High volume breast surgeons accept smaller excision margins for wide local excision--a national survey of the surgical management of wide local excision margins in UK breast cancer patients.

C. Griffith, James Harvey, Adam Hassani, 2013, Breast.

Multidisciplinary team working in cancer: what is the evidence?

Cath Taylor, Michael Richards, A. Munro, 2010, BMJ : British Medical Journal.

Breast cancer multi-disciplinary teams in England: much achieved but still more to be done.

J. Whelan, J M Whelan, C D M Griffith, 2006, Breast.

The use of a standard proforma in breast cancer reporting.

B. Angus, C. Griffith, M. Mathers, 2001, Journal of clinical pathology.

Multidisciplinary team working in cancer: what is the evidence?

A. Munro, R. Glynne-Jones, A. Ramirez, 2010, BMJ : British Medical Journal.